Management of anti-melanoma differentiation-associated gene 5 antibody-induced refractory dermatomyositis complicated by interstitial pneumonia using tofacitinib and its outcomes: a case report
The patient with anti-melanoma differentiation-associated gene 5 antibody-related rapidly progressive interstitial lung disease, whose disease was difficult to control after the administration of triple immunosuppressive therapy (steroids, tacrolimus, and cyclophosphamide), showed good response with tofacitinib. Unfortunately, the patient died of invasive pulmonary aspergillosis owing to severe immunosuppression; thus, the signs of complications should be promptly detected.
Authors
- Hirotaka Nishikiori (ORCID: https://orcid.org/0000-0002-0573-9344)
- Yuichiro Asai
- Yuki Mori (ORCID: https://orcid.org/0000-0002-9320-826X)
- Hirofumi Chiba (ORCID: https://orcid.org/0000-0002-7033-3084)
- Michiko Hosaka
- Takafumi Yorozuya (ORCID: https://orcid.org/0000-0002-4151-9883)
- Shun Kondoh
- Atsushi Saito (ORCID: https://orcid.org/0000-0003-3430-884X)
- Takumi Nishimaki
- Tatsuru Ishikawa
- Taku Hatakeyama
- Yui Imai
- Tomoyuki Takahashi (ORCID: https://orcid.org/0000-0002-8771-7666)
Institutions
- Sapporo Medical University (JP)
- Muroran Institute of Technology (JP)
Publication Details
- Journal
- Journal of Medical Case Reports
- Published
- 2024-09-28
- DOI
- https://doi.org/10.1186/s13256-024-04793-9
- Citations
- 1
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.39